BioCentury | Sep 9, 2020
Product Development

COVID-19 roundup: SpyBiotech-Serum Institute of India send HBV-based COVID-19 vaccine to clinic; plus Vaxart, Inovio-Thermo Fisher and RedHill

...as the highest titers of neutralizing antibodies.Inovio, Thermo Fisher vaccine production dealInovio Pharmaceuticals Inc. (NASDAQ:INO) announced Thermo Fisher Scientific Inc....
...consortium, which includes Richter-Helm BioLogics GmbH and Ology Bioservices Inc., for 100 million doses in 2021. Thermo Fisher...
...outpatient setting this year.TARGETSSPHK2 – Sphingosine kinase 2 BC Staff SpyBiotech Ltd. Serum Institute of India Vaxart Inc. Inovio Pharmaceuticals Inc. Thermo Fisher Scientific Inc. RedHill...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...acquisitions.  Among the largest was the $2.1 billion acquisition of viral vector manufacturer Brammer Bio by Thermo Fisher Scientific Inc....
...include the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher Scientific Inc. Brammer...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...has stepped down, a week after shareholders of the molecular diagnostics company rejected an $11.5 billion takeout bid from Thermo Fisher Scientific Inc....
BioCentury | Aug 15, 2020
Product Development

Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more

...pathology, Deb Hanks, the lab uses the TaqPath test kit from Thermo Fisher Scientific Inc....
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...to remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to be acquired by Thermo Fisher Scientific Inc....
...of shares were tendered by Qiagen shareholders, well below the minimum threshold of 66.7% . Thermo Fisher...
...take out the molecular diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher...
BioCentury | Mar 28, 2020
Management Tracks

Bernard joins Qiagen as CEO; plus CytomX, Recursion, 89bio, Heptares, Fusion, Freeline, Cognition, I-Mab, Seres and more

...biotech ramps up RNA extraction kit production to provide diagnostic testing during the COVID-19 pandemic. Thermo Fisher Scientific Inc....
BioCentury | Mar 24, 2020
Product Development

March 23 COVID-19 roundup: Gilead looks to expand access to remdesivir, antiviral gains Orphan designation; plus N.Y.’s chloroquine trial, Celltrion and more

...“Bumpy Ride for Debut of Verily’s COVID-19 Screening Platform” ). The tests are produced by Thermo Fisher Scientific Inc....
BioCentury | Mar 16, 2020
Product Development

COVID-19 Roundup: Trial starts for Moderna, Sanofi-Regeneron and BioNTech; plus Thermo Fisher, Roche and VIB

...Monday. EUA for Thermo Fisher’s diagnostic FDA issued an Emergency Use Authorization for a diagnostic from Thermo Fisher Scientific Inc....
...analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . BioCentury Staff BioNTech AG Moderna Inc. Sanofi Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Shanghai...
BioCentury | Mar 13, 2020
Politics, Policy & Law

U.S. moves to unlock COVID-19 test capacity

...while Qiagen’s test “could be ready within 12 weeks for EUA consideration by the FDA.” Thermo Fisher Scientific Inc....
...to sign up for our daily email. Steve Usdin, Washington Editor U.S. Food and Drug Administration (FDA) Roche Qiagen N.V. Thermo Fisher Scientific Inc. BARDA Luminex...
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...at Virion Biotherapeutics Ltd. (see "GammaDelta spins out Adaptate to focus on antibody therapies" ). Thermo Fisher Scientific Inc....
...from chief marketing officer. Robin Sawka, BioCentury Staff BioCentury Staff Genmab A/S Tricida Inc. Akcea Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo Fisher Scientific Inc. Fujifilm...
Items per page:
1 - 10 of 246
BioCentury | Sep 9, 2020
Product Development

COVID-19 roundup: SpyBiotech-Serum Institute of India send HBV-based COVID-19 vaccine to clinic; plus Vaxart, Inovio-Thermo Fisher and RedHill

...as the highest titers of neutralizing antibodies.Inovio, Thermo Fisher vaccine production dealInovio Pharmaceuticals Inc. (NASDAQ:INO) announced Thermo Fisher Scientific Inc....
...consortium, which includes Richter-Helm BioLogics GmbH and Ology Bioservices Inc., for 100 million doses in 2021. Thermo Fisher...
...outpatient setting this year.TARGETSSPHK2 – Sphingosine kinase 2 BC Staff SpyBiotech Ltd. Serum Institute of India Vaxart Inc. Inovio Pharmaceuticals Inc. Thermo Fisher Scientific Inc. RedHill...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...acquisitions.  Among the largest was the $2.1 billion acquisition of viral vector manufacturer Brammer Bio by Thermo Fisher Scientific Inc....
...include the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher Scientific Inc. Brammer...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...has stepped down, a week after shareholders of the molecular diagnostics company rejected an $11.5 billion takeout bid from Thermo Fisher Scientific Inc....
BioCentury | Aug 15, 2020
Product Development

Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more

...pathology, Deb Hanks, the lab uses the TaqPath test kit from Thermo Fisher Scientific Inc....
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...to remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to be acquired by Thermo Fisher Scientific Inc....
...of shares were tendered by Qiagen shareholders, well below the minimum threshold of 66.7% . Thermo Fisher...
...take out the molecular diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher...
BioCentury | Mar 28, 2020
Management Tracks

Bernard joins Qiagen as CEO; plus CytomX, Recursion, 89bio, Heptares, Fusion, Freeline, Cognition, I-Mab, Seres and more

...biotech ramps up RNA extraction kit production to provide diagnostic testing during the COVID-19 pandemic. Thermo Fisher Scientific Inc....
BioCentury | Mar 24, 2020
Product Development

March 23 COVID-19 roundup: Gilead looks to expand access to remdesivir, antiviral gains Orphan designation; plus N.Y.’s chloroquine trial, Celltrion and more

...“Bumpy Ride for Debut of Verily’s COVID-19 Screening Platform” ). The tests are produced by Thermo Fisher Scientific Inc....
BioCentury | Mar 16, 2020
Product Development

COVID-19 Roundup: Trial starts for Moderna, Sanofi-Regeneron and BioNTech; plus Thermo Fisher, Roche and VIB

...Monday. EUA for Thermo Fisher’s diagnostic FDA issued an Emergency Use Authorization for a diagnostic from Thermo Fisher Scientific Inc....
...analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . BioCentury Staff BioNTech AG Moderna Inc. Sanofi Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Shanghai...
BioCentury | Mar 13, 2020
Politics, Policy & Law

U.S. moves to unlock COVID-19 test capacity

...while Qiagen’s test “could be ready within 12 weeks for EUA consideration by the FDA.” Thermo Fisher Scientific Inc....
...to sign up for our daily email. Steve Usdin, Washington Editor U.S. Food and Drug Administration (FDA) Roche Qiagen N.V. Thermo Fisher Scientific Inc. BARDA Luminex...
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...at Virion Biotherapeutics Ltd. (see "GammaDelta spins out Adaptate to focus on antibody therapies" ). Thermo Fisher Scientific Inc....
...from chief marketing officer. Robin Sawka, BioCentury Staff BioCentury Staff Genmab A/S Tricida Inc. Akcea Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo Fisher Scientific Inc. Fujifilm...
Items per page:
1 - 10 of 246